12:05:56 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Beskrivning

LandNorge
ListaOAX Equities
SektorHälsovård
IndustriMedicinteknik
Observe Medical är ett norskt bolag verksamma inom medicinteknik. Bolaget bedriver utveckling av tekniska instrument som används inom intensivvården. Produkterna säljs under olika varumärken och är särskilt specialiserade för urinmätning. Störst verksamhet återfinns inom den nordiska samt europeiska marknaden. Bolaget kom till som en avknoppning från Navamedic och har sitt huvudkontor i Oslo.

Kalender

2022-11-03 Kvartalsrapport 2022-Q3
2022-08-25 Kvartalsrapport 2022-Q2
2022-06-03 Ordinarie utdelning OBSRV 0.00 NOK
2022-06-03 Kvartalsrapport 2022-Q1
2022-06-03 Årsstämma 2022
2022-03-29 Bokslutskommuniké 2021
2022-02-04 Extra Bolagsstämma 2022
2021-11-03 Kvartalsrapport 2021-Q3
2021-08-20 Kvartalsrapport 2021-Q2
2021-05-25 Ordinarie utdelning OBSRV 0.00 NOK
2021-05-21 Årsstämma 2021
2021-05-12 Kvartalsrapport 2021-Q1
2021-02-23 Bokslutskommuniké 2020
2020-11-03 Kvartalsrapport 2020-Q3
2020-08-18 Kvartalsrapport 2020-Q2
2020-07-01 Ordinarie utdelning OBSRV 0.00 NOK
2020-06-30 Årsstämma 2020
2020-06-16 Extra Bolagsstämma 2020
2020-05-12 Kvartalsrapport 2020-Q1
2020-02-25 Bokslutskommuniké 2019
2020-10-30 12:05:16
Observe Medical ASA, October 30, 2020:

On October 29, 2020, Observe Medical announced the signing of the final
agreement to acquire Sylak AB, a distributor of ICU/anaesthesia products in the
Swedish market, for an enterprise value of SEK 6 million (on a cash and debt
free basis).

All conditions in the agreement is met, and the transaction closed on October
30, 2020.

 "We are happy to finally conclude this important transaction for Observe
Medical and to be welcoming the Sylak team. They will be important in
accelerating the Nordic go-to-market strategy for Observe Medical's main product
Sippi®. At the same time, we have high ambitions for the continued development
of the Sylak portfolio success," CEO of Observe Medical Björn Larsson says.

Sylak had total revenues of SEK 13.4 million in 2019. Customers include several
of the largest hospitals in Sweden. Following completion of the transaction, the
Company plans to enter Norway and the rest of the Nordics with the combined
Sylak and Observe Medical portfolio. The transaction is financed through
existing cash.

For further information, please refer to the stock exchange announcements from
Observe Medical October 16 and October 29, 2020.

Contact person:
Björn Larsson, CEO of Observe Medical
Mobile: +46 76 620 17 25
E-mail: bjorn.larsson@observemedical.com

About Observe Medical

Observe Medical develops and markets innovative hospital products that
contribute to increased patient safety and a more efficient care system. The
company's headquarter is in Oslo and its operations are based out of Sweden.
Observe Medical's initial product Sippi®, is the only automated digital urine
meter with wireless data transfer to hospital patient data management systems,
and hinders bacterial migration that can lead to urinary infections (Sippcoat®).
Sippi® is CE marked and is currently being launched at selected hospitals in
Europe.